Table 1.

Demographics of patients enrolled in the study between March 2001 and March 2003

Patient number	Sex	Age	Metastasis site(s)
Renal cell carcinoma
1	F	66	Liver
2	F	70	Pancreas, liver
4	F	75	Lung
5	F	29	Retroperitoneal lymph nodes
6	M	45	Lung, bone
8	M	39	Lung, soft tissue
9	M	36	Lung, bone, soft tissue
10	M	44	Lung
11	M	34	Lung
12	M	66	Liver
13	M	66	Lung, bone
15	M	68	Lung
16	M	52	Liver, retroperitoneal
17	M	50	Lung, retroperitoneal
18	M	61	Liver, bones
19	M	53	Lung
20	M	54	Lung, bones
21	M	51	Liver, retroperitoneal
22	M	46	Lung
14a	M	70	Lung, soft tissue, adrenal, contralateral kidney
7a	M	78	Skin, central nervous system, bone
3a	F	32	Bone
Melanoma
2	F	34	Skin, lymph nodes, retroperitoneal
3	F	42	Breast, in transit
4	F	56	Lung
6	F	51	Liver, lung
8	M	40	In transit
9	M	2	Soft tissue, retroperitoneal
10	M	63	Lung, in transit
11	M	50	Gastrointestinal tract, skin
12	M	36	Lung, liver, pancreas
13	M	44	Lymph nodes
5a	F	41	Lung, in transit
7a	M	55	Liver, lung, spleen, bones

^aPatient who received only one dose of the vaccine and therefore was not evaluated further